Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Learn about effective wealth building actions for this year that can enhance your savings and investment strategies for long-term success.
23,492 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Wheels Up Experience is in the spotlight as its stock faces a sharp decline. This article breaks down the primary cau...
U.S. GDP rose at a 1.4% annualized pace in the fourth quarter, a sharp deceleration from earlier quarters. The report...
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
As BTC consolidates in 2026, Coinbase, BlackRock and Strategy emerge as the top on-chain holders. This report breaks ...
XRP nears a fifth straight red monthly candle, a pattern last seen in 2016-2017. Traders weigh whether history could ...
Paramount Global and Skydance are stepping up with a bigger offer for Warner Bros. Discovery, aiming to outpace Netfl...
Private exits are lagging as liquidity tightens in private markets. This report explains why the exploding secondarie...
Paramount Skydance has boosted its per-share bid for Warner Bros. Discovery to $31, intensifying the competition with...
A former francisco homeless charity chief faces nine felony counts after prosecutors allege more than $1.2 million in...
A major partnership reshapes Novo Nordisk's growth trajectory. This deep dive explains what the Vivtex deal means for...
A new consumer-ready humanoid named Neo hits preorder with a $20,000 price tag, promising to handle simple chores at ...